...
首页> 外文期刊>Equine Veterinary Journal >A randomised, blinded, crossover study to assess the efficacy of a feed supplement in alleviating the clinical signs of headshaking in 32 horses.
【24h】

A randomised, blinded, crossover study to assess the efficacy of a feed supplement in alleviating the clinical signs of headshaking in 32 horses.

机译:一项随机,双盲,交叉研究,旨在评估饲料添加剂在缓解32匹马摇晃的临床症状方面的功效。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Reasons for performing study: Feed supplements are commonly used by owners to alleviate headshaking; however, randomised, controlled trials are required to assess their efficacy. Objective: To determine the efficacy of a feed supplement for alleviation of the clinical signs of headshaking using a randomised, blinded, placebo-controlled trial. Methods: Using a crossover design, 44 horses previously diagnosed with chronic idiopathic headshaking received both the supplement and a matching placebo per os for 28 days with a washout period between of 14 days. Video recordings were taken at rest and exercise prior to the study and at the end of both periods of treatment. The degree of headshaking was assessed in a blinded, randomised manner by 2 veterinary surgeons. At the same time points, owners completed a questionnaire to assess the severity of headshaking signs. A Wilcoxon signed rank test was used to compare the scores while on supplement and placebo. Results: Using the video assessments, there was no significant difference between scores while on supplement compared with placebo (P=0.7). Using the questionnaire responses, there was no significant difference between scores for any activity when the placebo and the supplement were compared with each other. However, owners reported significant improvement during all activities for both placebo and supplement compared with pretreatment scores. Conclusions and potential relevance: The supplement offered no benefit over a placebo in alleviating the clinical signs of headshaking. There appeared to be a significant proxy placebo effect when the outcome was based on subjective owner perception of clinical signs. This study demonstrated no beneficial effect of this supplement on the clinical signs of headshaking. The study did show a significant placebo effect, thereby highlighting the necessity of properly conducted, randomised controlled trials, with blinding, to assess true treatment effects in trials in animals.
机译:进行研究的原因:业主通常使用饲料补充剂来减轻摇头;但是,需要随机对照试验来评估其疗效。目的:通过一项随机,盲法,安慰剂对照试验,确定饲料添加剂缓解头痛摇晃临床症状的功效。方法:采用交叉设计,先前诊断为慢性特发性摇晃的44匹马,口服接受补充剂和匹配的安慰剂28天,洗脱期为14天。在研究之前和两个治疗阶段结束时,都在休息和运动时进行了录像。摇晃的程度由两名兽医以盲法,随机的方式进行评估。在同一时间点,业主填写了一份问卷,以评估摇晃迹象的严重性。使用Wilcoxon签名等级检验比较补充剂和安慰剂时的得分。结果:使用视频评估,补充剂与安慰剂相比得分之间无显着差异(P = 0.7)。使用问卷调查表的答复,将安慰剂和补充剂相互比较时,任何活动的得分之间都没有显着差异。然而,与治疗前评分相比,拥有者报告安慰剂和补充剂在所有活动中都有显着改善。结论和潜在的相关性:该补充剂在缓解头痛的临床症状方面没有优于安慰剂的益处。当结果是基于主观所有者对临床体征的认识时,似乎存在明显的代用安慰剂作用。这项研究表明该补充剂对摇头的临床症状没有有益的作用。这项研究确实显示了显着的安慰剂作用,从而强调了正确进行随机对照试验(盲法)以评估动物试验中真实治疗效果的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号